LumiQ

Turnkey solution for autoimmune disease

• The combination of MosaiQ^® and LumiQ platforms provides a unique, automated, seamlessly integrated solution to cover your needs for screening and identification of autoantibodies for a wide range of diseases.

The LumiQ system is designed to provide workflow efficiency from patient sample in, to result out.

We aim to empower better informed, personalized clinical decisions, improving quality of care and reducing the burden of chronic illnesses for patients in need.

Indirect immunofluorescence remains the standard method for testing of various antibodies. The detection and measurement of autoantibodies have significantly evolved with automation, offering laboratories more enhanced options.

Offering a new level of performance from a benchtop immunofluorescence solution, the LumiQ platform will be able to perform two batches simultaneously, automated from patient sample to result.

Designed to Provide Fast, Actionable Insights with an Intuitive User Experience